SCHEMBL6975580

SCHEMBL6975580

CCCN(CCC)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN(C)C)cc1)c1ccccc1)C(=O)N2

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.43
HDAC6 Q9UBN7 7/20 0.43
ALDH1A1 P00352 1/20 0.41
LIMK1 P53667 2/20 0.38
HDAC3 O15379 3/20 0.38
HDAC2 Q92769 3/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
ROCK2 O75116 1/20 0.37
RORC P51449 1/20 0.37
TP53 P04637 1/20 0.36
LIMK2 P53671 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6975585 1.00 HDAC1 (0.43) HDAC1HDAC6ALDH1A1LIMK1HDAC3
SCHEMBL6985372 0.94 HDAC1 (0.42) HDAC1HDAC6ALDH1A1LIMK1RORC
SCHEMBL6985368 0.94 HDAC1 (0.42) HDAC1HDAC6ALDH1A1LIMK1RORC
SCHEMBL6978220 0.91 LIMK1 (0.39) HDAC1HDAC6ALDH1A1LIMK1TP53
SCHEMBL6978224 0.91 LIMK1 (0.39) HDAC1HDAC6ALDH1A1LIMK1TP53
SCHEMBL6978234 0.91 TP53 (0.41) HDAC1HDAC6ALDH1A1LIMK1HDAC3
SCHEMBL6978230 0.91 TP53 (0.41) HDAC1HDAC6ALDH1A1LIMK1HDAC3
SCHEMBL6984569 0.90 JAK3 (0.42) HDAC1HDAC3HDAC2ROCK2
SCHEMBL6984575 0.90 JAK3 (0.42) HDAC1HDAC3HDAC2ROCK2
SCHEMBL8187758 0.90 NAMPT (0.42) HDAC1HDAC6HDAC3HDAC2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
US-6169106-B1 ANTITUMOUR AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-01-02 US disclosed